✦ LIBER ✦

Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer

✍ Scribed by William N. William Jr; Merrill S. Kies; Frank V. Fossella; Diane D. Liu; Gregory Gladish; Warner H. Tse; J. Jack Lee; Waun K. Hong; Scott M. Lippman; Edward S. Kim

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 183 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24996

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab in combination with carboplati

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer : A multicenter phase 2 study

✍ Chandra P. Belani; Marshall T. Schreeder; Ronald G. Steis; Richard A. Guidice; T 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Carboplatin and docetaxel in advanced no

Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study

✍ Sakkaraiappan Ramalingam; TracyW. Dobbs; AviI. Einzig; Slawomir Wojtowicz-Praga; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 181 KB

Phase II study of pemetrexed in combinat

Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer

✍ Ralph G. Zinner; Frank V. Fossella; Gregory W. Gladish; Bonnie S. Glisson; Georg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 3 views

Phase I study of second-line chemotherap

Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer

✍ Mikio Oka; Minoru Fukuda; Seiji Nagashima; Masaaki Fukuda; Akitoshi Kinoshita; H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 84 KB

A phase 2 study of cetuximab in combinat

A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer

✍ Edward S. Kim; Ann M. Mauer; William N. William Jr; Hai T. Tran; Diane Liu; Jack 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

A phase II study of weekly docetaxel plu

A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma

✍ Ji-Youn Han; Dae Ho Lee; Hae Young Kim; Eun Kyung Hong; Sung Min Yoon; Jong Ho C 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND Docetaxel is an active agent in advanced nonsmall‐cell lung carcinoma (NSCLC) and demonstrates preclinical and clinical synergism with capecitabine. We conducted the current Phase II study to evaluate the efficacy and safety of the docetaxel/capecitabine combination in ch